The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Grant Stuart since 2008.
The trader's CIK number is 1410397.
At the time of the last reporting, Grant Stuart was the SR VP & CFO of Biocryst Pharmaceuticals Inc. (stock ticker symbol BCRX).
Also see all insider trading activities at Biocryst Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | BCRX | 0 | $0 | 22,615 | $76,777 | 65,000 | $78,000 |
| 2010 | BCRX | 0 | $0 | 77,338 | $590,910 | 60,311 | $152,839 |
| 2009 | BCRX | 3,000 | $4,845 | 0 | $0 | 0 | $0 |
| 2008 | BCRX | 3,000 | $8,466 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-03-16 | BCRX | Option Ex | 65,000 | 1.20 | 78,000 |
| 2011-03-16 | BCRX | Sale | 22,615 | 3.40 | 76,777 |
| 2010-08-04 | BCRX | Sale | 2,500 | 6.20 | 15,500 |
| 2010-08-04 | BCRX | Option Ex | 2,500 | 1.20 | 3,000 |
| 2010-06-03 | BCRX | Sale | 1,250 | 6.97 | 8,712 |
| 2010-06-03 | BCRX | Option Ex | 1,250 | 1.20 | 1,500 |
| 2010-05-03 | BCRX | Option Ex | 1,250 | 1.20 | 1,500 |
| 2010-05-03 | BCRX | Sale | 1,250 | 7.68 | 9,600 |
| 2010-04-28 | BCRX | Sale | 1,563 | 8.26 | 12,910 |
| 2010-04-29 | BCRX | Sale | 36,990 | 8.31 | 307,386 |
| 2010-04-28 | BCRX | Option Ex | 1,563 | 3.26 | 5,095 |
| 2010-04-29 | BCRX | Option Ex | 36,990 | 3.26 | 120,587 |
| 2010-04-12 | BCRX | Option Ex | 509 | 3.26 | 1,659 |
| 2010-04-12 | BCRX | Sale | 509 | 8.26 | 4,204 |
| 2010-04-05 | BCRX | Sale | 1,249 | 6.96 | 8,699 |
| 2010-04-05 | BCRX | Option Ex | 1,249 | 1.20 | 1,498 |
| 2010-03-03 | BCRX | Sale | 15,000 | 6.96 | 104,370 |
| 2010-03-03 | BCRX | Option Ex | 15,000 | 1.20 | 18,000 |
| 2010-01-22 | BCRX | Sale | 17,027 | 7.02 | 119,529 |
| 2009-01-30 | BCRX | Buy | 3,000 | 1.61 | 4,845 |
| 2008-08-04 | BCRX | Buy | 3,000 | 2.82 | 8,466 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Grant Stuart (SR VP & CFO of Biocryst Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.